This site is intended for healthcare professionals
Whats on the horizon?
  • Home
  • /
  • News
  • /
  • 2019
  • /
  • 09
  • /
  • NEW: Moderate to Severe Asthma Learning Zone launc...
Insight

NEW: Moderate to Severe Asthma Learning Zone launches on Medthority.com

Read time: 1 mins
Last updated:27th Sep 2019
Published:27th Sep 2019
Source: Medthority

Despite being a well-documented condition, Asthma can still prove challenging to healthcare professionals who want to identify the most effective approaches to optimizing management strategies.

We've developed the Moderate to Severe Asthma Learning Zone to help further your knowledge of moderate and severe asthma and its management, specific to stages 3-5 of the Global Initiative for Asthma (GINA) stepwise approach to asthma treatment.

Read on to get an overview of some of the educational resources now available online.

Asthma overview
Top-up your learning or get a comprehensive overview to enhance your knowledge and understanding of asthma, including sections on the burden of the disease, classification and phenotyping and the symptoms.
Explore here

Asthma Management  
How well do you understand the latest guidance for adult and paediatric asthma and asthma exacerbations?
Find out more

Pathophysiology
Take a deep-dive into the inflammatory cascade by discovering more about potential therapeutic targets, as well as the treatments for some cases of severe asthma.
Find out more

The Moderate to Severe Asthma Learning Zone has been developed by Medthority for Medthority.com, in collaboration with Novartis Pharma AG, with some content provided by Novartis Pharma AG (with the exception of the ERS Daily Blog content which has been created independently and with no input from the sponsor). Date of preparation: September 2019 (GLRESP/RESP/0337)

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.